URGN
UroGen Pharma Ltd.Company with tickers: URGN
CIK
1668243
CUSIP
M96088105
Shares Outstanding
48,721,701
13F Activity (30d)
140 filings
135 filers
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-05-08 | Schoenberg Mark | Officer | 10,000 | 2026-05-08 | RBC CAPITAL MARKETS LLC |
| 2026-02-03 | Schoenberg Mark | Officer | 13,333 | 2026-02-02 | Oppenheimer & Co. Inc |
| 2025-11-19 | Schoenberg Mark | Officer | 10,000 | 2025-11-19 | RBC CAPITAL MARKETS LLC |
| 2025-09-09 | Schoenberg Mark | Officer | 871 | 2025-09-08 | Oppenheimer & Co. Inc. |
| 2025-09-09 | Smith Jason Drew | Officer | 1,520 | 2025-09-08 | Oppenheimer& Co. |
| 2025-07-29 | Schoenberg Mark | Officer | 5,149 | 2025-07-28 | Oppenheimer & Co. Inc. |
| 2025-07-29 | Smith Jason Drew | Officer | 7,522 | 2025-07-28 | Oppenheimer & Co. Inc. |
| 2025-06-10 | Schoenberg Mark | Officer | 5,162 | 2025-06-09 | Oppenheimer & Co. Inc. |
| 2024-09-10 | Schoenberg Mark | Officer | 859 | 2024-09-09 | Oppenheimer & Co. Inc. |
| 2024-06-11 | Schoenberg Mark | Officer | 5,153 | 2024-06-10 | Oppenheimer & Co. Inc. |
| 2024-03-18 | Schoenberg Mark | Officer | 12,000 | 2024-03-18 | RBC WEALTH MANAGEMENT |
| 2024-02-01 | Schoenberg Mark | Officer | 3,789 | 2024-01-31 | Oppenheimer & Co. Inc. |
| 2024-02-01 | Smith Jason Drew | Officer | 4,993 | 2024-01-31 | Oppenheimer & Co. Inc. |
Showing 1–13 of 13 filings